Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.
about
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansPostprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.The regulatory role of DPP4 in atherosclerotic disease.Glucagon-like peptide-2 regulates release of chylomicrons from the intestine.Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsMinor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.Identification of compound-protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds.Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.GLP-1 based therapies: clinical implications for gastroenterologists.Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studiesPostprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents.Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, plEffects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.Effect of sitagliptin therapy on triglyceride-rich lipoprotein kinetics in patients with type 2 diabetes.
P2860
Q26774776-E0A81814-BA9D-4F2A-8353-E173C03F1875Q30362026-BC7D7BE0-25BF-4A71-912F-E89D782B61C4Q33805518-9F62813D-47FB-4769-9CF1-8F6125A86BEBQ35046115-E975F3C0-0FCE-4350-884C-D1DABD6E43F2Q35624667-054F09E7-48E4-4D37-ADF1-1C8068F089E6Q35890612-7453F334-7A02-4886-A16C-0B4243E26DE4Q35928257-3A58112C-2871-4067-8399-68E9C0074059Q36105215-5F79EEB6-FC73-4579-B86A-4CC81EA8951AQ36466692-716D9513-F152-4603-A39C-36E1C73B971FQ38242314-B4426B7D-0B56-4F53-8289-C7E3392DFEA9Q38413395-8C1FD793-CCE0-462C-8F0A-BE9AE0E96E8BQ38703292-B4B223B4-C790-4415-AFC1-E193CB2B4051Q38912469-664869ED-0B6A-4795-B065-382E4C7A1BF0Q42635500-77CC060B-1BFF-466F-B626-F88FCA8083EAQ42659870-5BEDEE0B-CAA1-4350-BD0E-44CDDA71957FQ47134180-F02FD628-B062-491C-AA8F-874E874A0489Q51233383-47E669D8-559D-4AFB-BD9E-008FF3C7AC75Q51276064-34CAA325-6165-4AE7-97FA-17381A015081Q51318376-91AD3263-2792-4C60-B42C-302C8CE39516
P2860
Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@ast
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@en
type
label
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@ast
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@en
prefLabel
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@ast
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@en
P2860
P50
P356
P1433
P1476
Sitagliptin, a DPP-4 inhibitor ...... e secretion in healthy humans.
@en
P2093
Gary F Lewis
Satya Dash
P2860
P304
P356
10.2337/DB13-1654
P407
P577
2014-02-28T00:00:00Z